Article
Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patient
2019-09-16
Abstract excerpt
Neuraminidase (NA) inhibitors (NAIs), including oseltamivir and zanamivir, play an important therapeutic role against influenza infections in immunocompromised patients. In such settings, however, NAI therapy may lead to the emergence of resistance involving mutations within the influenza surface genes. The aim of this study was to investigate the evolution of hemagglutinin (HA) and NA genes of influenza A(H1N1)pd...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 53e120c8-222e-5bbd-8921-1b3693916216
- DOI
- 10.1101/768614
